Answers are grounded in this paper and cite their sources.
“Precision” has become a broadly applied label in psychiatry, and encompasses different uses of MRI in transcranial magnetic stimulation (TMS) for depression. The recent trial by Taylor and colleagues [1] is a genuine milestone: individualized connectivity-guided targeting outperformed Beam F3 in accelerated intermittent theta-burst stimulation (iTBS), with response rates of 80% versus 60%. Li and colleagues [2] similarly found that structural connectivity-guided targeting outperformed the 5-cm rule at week 2, while both structural- and functional-connectivity-guided targeting showed advantages by week 6.
No takes yet. Share an insight, caveat, or question.
Lynch et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: